Lymphoma & Leukaemia Watch 45 – MRD in CLL… what is it and does it matter?

Cardiology Watch 22 – Gene-based therapy for dyslipidaemia

The role of ivosidenib in patients with locally advanced or metastatic mIDH1 cholangiocarcinoma – presented by Associate Professor Matthew Burge

Click here for TIBSOVO Product Information https://rss.medsinfo.com.au/se/pi.cfm?product=septibso   

Gynaecological Cancer Research Review, Issue 21

Respiratory Watch 9 – Update on lung nodule biopsies

Gastroenterology Watch 28 – Optical Diagnosis: Do you know what you are looking at?

Diabetes Watch 5 – Increased risk of dementia in type 1 diabetes

Study Review – Efficacy and safety of advanced therapies for moderately to severely active ulcerative colitis at induction and maintenance

Study Review – The CheckMate 8HW trial

Study Review – GLOW Study update: Long-term efficacy and safety of ibrutinib-venetoclax in first-line CLL